Armonica Technologies is an Albuquerque, NM based company focused on building its proprietary long-read DNA sequencing technology. The Company’s mission is to become the gold standard of DNA sequencing for precision medicine research applications. The Company’s technology is based upon a portfolio of patented and patent pending technologies licensed from STC.UNM.

Today’s standard genome sequencing approaches require extensive library preparation and create a massive computational and bioinformatics problem related to reassembling the data set. Armonica’s technology, called optical nanopore sequencing, uses proprietary nanochannels to deliver single DNA molecules through nanopores. Armonica’s approach will lead to faster, more thorough and more accurate genomic analysis than is currently available, without the need for library preparation. The Company’s innovative platform will enable life science researchers to be more efficient and productive in their research and discovery capabilities.